|
| | Publication Year | Title | Author(s) |
| 1 | 16-Jan-2024 | Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies. | Lee, Sze Ting ; Kovaleva, Natalia; Senko, Clare ; Kee, Damien ; Scott, Andrew M |
| 2 | 22-Sep-2023 | Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour. | Klein, Oliver ; Palmer, Jodie ; Behren, Andreas; Cebon, Jonathan S ; Kee, Damien |
| 3 | 1-Sep-2023 | A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review. | Abdelmogod, Arwa; Papadopoulos, Lia; Riordan, Stephen; Wong, Melvin; Weltman, Martin; Lim, Ratana; McEvoy, Christopher; Fellowes, Andrew; Fox, Stephen; Bedő, Justin; Penington, Jocelyn; Pham, Kym; Hofmann, Oliver; Vissers, Joseph H A; Grimmond, Sean; Ratnayake, Gayanie; Christie, Michael; Mitchell, Catherine; Murray, William K; McClymont, Kelly; Luk, Peter; Papenfuss, Anthony T; Kee, Damien ; Scott, Clare L; Goldstein, David; Barker, Holly E |
| 4 | 20-Aug-2023 | Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma. | Robert, Caroline; Carlino, Matteo S; McNeil, Catriona; Ribas, Antoni; Grob, Jean-Jacques; Schachter, Jacob; Nyakas, Marta; Kee, Damien ; Petrella, Teresa M; Blaustein, Arnold; Lotem, Michal; Arance, Ana; Daud, Adil I; Hamid, Omid; Larkin, James; Anderson, James; Krepler, Clemens; Grebennik, Dmitri; Long, Georgina V |
| 5 | 4-May-2023 | Targeting homologous recombination deficiency in uterine leiomyosarcoma | Dall, Genevieve; Vandenberg, Cassandra J; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H A; Bedő, Justin; Penington, Jocelyn; Wakefield, Matthew J; Kee, Damien ; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P; Dobrovic, Alexander ; Fox, Stephen B; McNally, Orla; Power, Jeremy D; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M; Klein, Oliver ; Barnett, Stephen A ; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T; Scott, Clare L; Barker, Holly E |
| 6 | 1-Apr-2023 | Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers? | Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S |
| 7 | 2023 | The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models. | Ho, Gwo Yaw; Vandenberg, Cassandra J; Lim, Ratana; Christie, Elizabeth L; Garsed, Dale W; Lieschke, Elizabeth; Nesic, Ksenija; Kondrashova, Olga; Ratnayake, Gayanie; Radke, Marc; Penington, Jocelyn S; Carmagnac, Amandine; Heong, Valerie; Kyran, Elizabeth L; Zhang, Fan; Traficante, Nadia; Huang, Ruby; Dobrovic, Alexander ; Swisher, Elizabeth M; McNally, Orla; Kee, Damien ; Wakefield, Matthew J; Papenfuss, Anthony T; Bowtell, David D L; Barker, Holly E; Scott, Clare L |
| 8 | Nov-2021 | Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial. | Klein, Oliver ; Kee, Damien ; Gao, Bo; Markman, Ben; da Gama Duarte, Jessica; Quigley, Luke; Jackett, Louise A ; Linklater, Richelle; Strickland, Andrew; Scott, Clare; Mileshkin, Linda; Palmer, Jodie ; Carlino, Matteo; Behren, Andreas; Cebon, Jonathan S |
| 9 | 15-Sep-2021 | Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. | Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study, null; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L |
| 10 | 28-Jul-2021 | Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma. | Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Eftekhariyan Ghamsari, Mohammad Reza; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Cancer Study, Australian Ovarian; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L |
| 11 | 29-Apr-2021 | Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy. | Klein, Oliver ; Kee, Damien ; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie ; Power, Daniel; Cebon, Jonathan S ; Behren, Andreas |
| 12 | 12-Apr-2021 | Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538. | Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S |
| 13 | Dec-2020 | Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1 immunotherapy. | Lasocki, Arian; Kee, Damien |
| 14 | 1-Sep-2020 | Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers: Subgroup Analysis of a Phase 2 Nonrandomized Clinical Trial. | Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Jackett, Louise A ; Lum, Caroline; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S |
| 15 | Sep-2020 | Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers. | Klein, Oliver ; Kee, Damien ; Markman, Ben; Michael, Michael; Underhill, Craig; Carlino, Matteo S; Jackett, Louise A ; Lum, Caroline; Scott, Clare; Nagrial, Adnan; Behren, Andreas; So, Jane Y; Palmer, Jodie ; Cebon, Jonathan S |
| 16 | 5-Sep-2019 | Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature. | Gunjur, Ashray ; Klein, Oliver ; Kee, Damien ; Cebon, Jonathan S |
| 17 | 12-Nov-2018 | Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series. | Mitchell, Emma L; Lau, Peter Kar Han; Khoo, Chloe; Liew, David F; Leung, Jessica; Liu, Bonnia ; Rischin, Adam; Frauman, Albert G ; Kee, Damien ; Smith, Kortnye; Brady, Benjamin; Rischin, Danny; Gibson, Andrew; Mileshkin, Linda; Klein, Oliver ; Weickhardt, Andrew; Arulananda, Surein; Shackleton, Mark; McArthur, Grant; Östör, Andrew; Cebon, Jonathan S ; Solomon, Benjamin; Buchanan, Russell R C ; Wicks, Ian P; Lo, Serigne; Hicks, Rodney J; Sandhu, Shahneen |
Loading...
2
0
20
0
false